Mysten Labs
Founded in 2021, Mysten Labs develops foundational web3 infrastructure, including the Sui blockchain, to support a decentralized internet.
Secondary Market Price
How Mysten Labs Measures Up
To help you manage your Mysten Labs equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
Series B
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Mysten Labs's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Mysten Labs Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Mysten Labs's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Mysten Labs is a technology company that provides infrastructure for web3, with a primary focus on developing its Sui blockchain ecosystem. The company's current activities involve building foundational technologies to support a decentralized internet, including contract development and crypto infrastructure. Founded in 2021 by Evan Cheng, Sam Blackshear, Adeniyi Abiodun, and George Danezis, the company is headquartered in San Francisco, CA. In October 2022, Mysten Labs raised $300 million in a Series B funding round.
The company is expanding its focus toward institutional markets and onchain financial services, having recently hired a Head of Capital Markets from Goldman Sachs. Recent announcements include a partnership with Google as a launch partner for its Agentic Payments Protocol, which enables AI agents to conduct transactions. Mysten Labs also launched Seal, a data privacy and access control solution on the Sui Mainnet, and developed ByteCrane, a proof-of-concept with Bhutan’s DHI InnoTech that allows IoT devices in offline environments to send signed data to the Sui blockchain. Additionally, in 2024, the SEC approved a 2x leveraged SUI exchange-traded fund (ETF) on the Nasdaq exchange.
- FTX Ventures
- Andreessen Horowitz
- Jump Crypto
- Apollo
- Binance Labs
- Franklin Templeton
- Coinbase Ventures
- Circle Ventures
- Lightspeed Venture Partners
- Sino Global
- Dentsu Ventures
- Greenoaks Capital
- O'Leary Ventures
- Co-Founder, CEO Evan Cheng
- Co-Founder, CTO Sam Blackshear
- Co-Founder, CPO Adeniyi Abiodun
- Co-Founder, Chief Cryptographer Kostas Chalkias
- Co-Founder, Chief Scientist George Danezis
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Mysten Labs worth joining?
Deciding to join a startup like Mysten Labs involves evaluating both the role and the potential value of your equity compensation. Tools like Prospect can help you forecast your equity's future value and compare it to other opportunities, giving you a clearer picture of the total compensation package.
What should I do with my Mysten Labs stock?
Managing your Mysten Labs stock requires a strategy for when to exercise options and whether to sell shares during liquidity events or hold them. Platforms like Prospect offer customized option exercise strategies and tools to help you make tax-optimal decisions based on your financial goals.
Can you sell Mysten Labs stock?
Selling stock in a private company like Mysten Labs is typically possible during specific liquidity events, such as tender offers or on secondary markets. Prospect provides tender offer tools and secondary market data to help you decide how much to sell and which shares are the most tax-optimal.
How can I find the value of my Mysten Labs stock?
Valuing stock in a private company like Mysten Labs is challenging as it isn't publicly traded and its price isn't readily available. You can use platforms like Prospect, which leverage proprietary predictive models to forecast your equity's potential value based on various market signals.
What is Mysten Labs's equity worth?
The precise worth of Mysten Labs's equity is not public information and depends on factors like its latest valuation and future growth prospects. To get a data-driven estimate, you can use resources like Prospect to project a range of likely outcomes for your equity's value.
What is Mysten Labs's stock ticker symbol?
As a private company, Mysten Labs does not have a stock ticker symbol. Ticker symbols are assigned to companies only when they become publicly traded on a stock exchange.
Can I buy or sell Mysten Labs stock?
Employees can "buy" stock by exercising their options, and selling is possible during company-approved liquidity events like tender offers. For those who are not employees, purchasing shares in a private company like Mysten Labs is generally not possible as it is not open to public investment.
What is the criteria to buy or invest in Mysten Labs stock?
Investing in a private company like Mysten Labs is typically restricted to employees who receive equity as part of their compensation. Otherwise, opportunities to invest are usually limited to venture capital firms and accredited investors during official fundraising rounds.
